COVID-19: urgent actions, critical reflections and future relevance of 'WaSH': lessons for the current and future pandemics.


Journal

Journal of water and health
ISSN: 1477-8920
Titre abrégé: J Water Health
Pays: England
ID NLM: 101185420

Informations de publication

Date de publication:
Oct 2020
Historique:
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 30 10 2020
Statut: ppublish

Résumé

The COVID-19 pandemic placed hygiene at the centre of disease prevention. Yet, access to the levels of water supply that support good hand hygiene and institutional cleaning, our understanding of hygiene behaviours, and access to soap are deficient in low-, middle- and high-income countries. This paper reviews the role of water, sanitation and hygiene (WaSH) in disease emergence, previous outbreaks, combatting COVID-19 and in preparing for future pandemics. We consider settings where these factors are particularly important and identify key preventive contributions to disease control and gaps in the evidence base. Urgent substantial action is required to remedy deficiencies in WaSH, particularly the provision of reliable, continuous piped water on-premises for all households and settings. Hygiene promotion programmes, underpinned by behavioural science, must be adapted to high-risk populations (such as the elderly and marginalised) and settings (such as healthcare facilities, transport hubs and workplaces). WaSH must be better integrated into preparation plans and with other sectors in prevention efforts. More finance and better use of financing instruments would extend and improve WaSH services. The lessons outlined justify no-regrets investment by government in response to and recovery from the current pandemic; to improve day-to-day lives and as preparedness for future pandemics.

Identifiants

pubmed: 33095188
doi: 10.2166/wh.2020.162
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

613-630

Auteurs

Guy Howard (G)

Department of Civil Engineering, University of Bristol, Bristol, UK E-mail: guy.howard@bristol.ac.uk; † Co-first-authors.

Jamie Bartram (J)

School of Civil Engineering, University of Leeds, Leeds, UK; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; † Co-first-authors.

Clarissa Brocklehurst (C)

Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; ‡ Authors in alphabetical order.

John M Colford (JM)

Division of Epidemiology, University of California, Berkeley, CA, USA; ‡ Authors in alphabetical order.

Federico Costa (F)

Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil; ‡ Authors in alphabetical order.

David Cunliffe (D)

Department for Health and Wellbeing, Adelaide, South Australia, Australia; ‡ Authors in alphabetical order.

Robert Dreibelbis (R)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK; ‡ Authors in alphabetical order.

Joseph Neil Spindel Eisenberg (JNS)

Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA; ‡ Authors in alphabetical order.

Barbara Evans (B)

School of Civil Engineering, University of Leeds, Leeds, UK; ‡ Authors in alphabetical order.

Rosina Girones (R)

Department of Genetics, Microbiology and Statistics, University of Barcelona, Barcelona, Spain; ‡ Authors in alphabetical order.

Steve Hrudey (S)

Faculty of Medicine and Dentistry, University of Alberta, Alberta, Canada; ‡ Authors in alphabetical order.

Juliet Willetts (J)

Institute for Sustainable Futures, University of Technology Sydney, Sydney, Australia; ‡ Authors in alphabetical order.

Caradee Y Wright (CY)

Environmental and Health Research Unit, South African Medical Research Council, Department of Geography, Geoinformatics and Meteorology, University of Pretoria, Pretoria, South Africa; ‡ Authors in alphabetical order.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH